Main Article Content
Aims: This study assessed histological parameter of the hippocampus using scopolamine-induced cognitive dysfunction rats following the administration of aqueous extract of Telfairia occidentalis seed.
Materials and Methods: Thirty Wistar rats weighed between 180-200 g were randomly grouped into five, designated I, II, III, IV and V each containing six rats. Cognitive dysfunction was induced in groups II to V by intraperitoneal administration of 1 mg/kg body weight of scopolamine for seven days before the aqueous extract administration. Group I were fed with animal feed and water ad libitum. Groups III and IV received 875 and 1750 mg/kg body weight of aqueous extract of Telfairia occidentalis seed while group V received 1 mg/kg body weight of donepezil for fourteen days. Twenty-four hours after the last administration, the animals were anaesthetized with their brain tissues perfused, processed and stained with haematoxylin and eosin.
Results: Results showed atrophied and karyorrhectic cells with disrupted cell membranes in group II. These pathological features were less in groups III and V but none in group IV when compared to group I. The ameliorative effect of aqueous extract of T. occidentalis may be attributed to the presence of exogenous antioxidants which helps to neutralize the toxic effects caused by scopolamine.
Conclusion: In conclusion, the cellular damage caused by scopolamine hydrobromide was reduced in dose dependent manner following administration of aqueous extract of T. occidentalis seed.
(Retrieved February 7, 2015)
Commenges D, Scotet V, Renaud S, Jacqmin-Gadda H, Barberger-Gateau P, Dartigues JF. Intake of flavonoids and risk of dementia. Eur J of Epi. 2000;16(4): 357–363.
Blendon RJ, Benson JM, Wikler EM, Weldon KJ, Georges J, Baumgart M, et al. The impact of experience with a family member with Alzheimer’s disease on views about the disease across five countries. Int J of Alz Dis. 2012;903-912.
Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: A systematic review and metaanalysis. Alzh and Dement. 2013;9(1):63–75.
Akter SFU, Rani MFA, Nordin MS, Ab-Rahman J, Aris, MAB, Rathor MY. Dementia: Prevalence and risk factors. Intl Rew of Soc Sci and Hum. 2012;2(2):176–184.
Paddick S, Longdon AR, Kisoli A, Dotchin C, Gray WK, Dewhurst F. Dementia prevalence estimates in sub-Saharan Africa: Comparison of two diagnostic criteria. Glo Health Act. 2013;6:1–7.
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: A Delphi consensus study. The Lancet. 2005;366 (9503):2112–2117.
Paraïso MN, Guerchet M, Saizonou J, Cowppli-Bony P, Mouanga AM, Nubukpo P, et al. Prevalence of dementia among elderly people living in Cotonou, an urban area of Benin (West Africa), Neuroepi. 2011;36(4):245–251.
Guerchet M, Houinato D, Paraiso MN, von Ahsen N, Nubukpo P, Otto M, et al. Cognitive impairment and dementia in elderly people living in rural Benin, West Africa. Dementia and Geriat Cog Dis. 2009;27(1):34–41.
Hendrie HC, Osuntokun BO, Hall KS, Ogunniyi AO, Hui SL, Unverzagt FW. Prevalence of Alzheimer’s disease and dementia in two communities: Nigerian Africans and African Americans. The Ame J of Psych. 1995;152(10):1485–1492.
Davies A, Ansa A, Martinsixtus E, Kit C, Ayo O, Michael OH, et al. Prevalence of dementia in Nigeria: A systematic review of the evidence. J of Glo Health Rep. 2019;3.e2019014.
Alzheimer Association. Alzheimer disease facts and figures. Alzheimers Dement. 2017;4(2):325-373.
Kummar S, Gutierrez M, Doroshow JH, Murgo AJ. Drug development in oncology: classical cytotoxics and molecularly targeted agents. Brit J of Clin Phar. 2006;1 (62):15-26.
Gillette GS, Abellan VKG, Andrieu S, Barberger GP, Berr C, Bonnefoy M. IANA task force on nutrition and cognitive decline with aging. The J of Nutri Health and Aging. 2007;11:132–52.
Nkosi CZ, Okpoku AR, Terbalanche S E. Antioxidative effects of pumpkin seed (Cucurbita pepo) protein isolate in CCl4-Induced liver injury in low-protein fed rats. Phyto Res. 2006;20(11):935-40.
Apostolova LG, Green AE, Babakchanian S, Hwang KS, Chou YY, Toga AW, et al. Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment and Alzheimer’s disease. Alz Dis and Asso Dis. 2012;26 (1):17–27.
Nitta A, Katono Y, Itoh A, Hasegawa T, Nabeshima T. Nicotine reverse scopolamine-induced impairment of performance in passive avoidance task in rats through its action on the dopaminergic neuronal system. Phar Biochem and Beh. 2002;49:807-812.
Oh JH, Choi BJ, Chang MS, Park K S. Nelumbo nucifera semen extract improves memory in rats with scopolamine-induced amnesia through the induction of choline acetylcholinesterase expression. Neurosci Let. 2009;55(1):41-44.
Fan Y, Hu J, Li J, Yang Z, Xin X, Wang J, et al. Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms. Neurosci Let. 2005;374(3): 222-226.
Deb D, Nayak V, Bairy KL, Rao KG, Shetty J, Hegde MV, et al. Antiamnesic and neuroprotective effects of low dose of Ramipril and Losartan in scopolamine-induced Amnesia Model of Dementia. Res J of Pharm, Bio and Chem Sci. 2013;4(1): 1174-1182.
Zou L, Zhou T, Pannell BK, Ziegler AC, Best TM. Biological and physiological role of reactive oxygen species: the good, the bad and the ugly. Acta Physiol. 2015;214: 329-348.
Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nat. 2006; 443:787-795.
Cavanagh JB. The problems of neurons with long axons. Lancet. 1984;2:1284-1287.
George D, Scneider E. Encyclopedia of Medicinal Plants. 1998;246-249.
Owoeye O, Gabriel MO. Protective effects of aqueous extract of Telfairia occidentalis on mercury-induced histological and oxidative changes in the rat. Hippocampus and Cerebellum. Afr J of Biomed Res. 2016;19:241-247.
Pharm-Huy LA, He H, Phar-Huy C. Free radical. Antioxidants in disease and health. Inter J of Biomed Sci. 2008;4(2): 89-96.